Consumer Defensive · Household & Personal Products
Made onSep 11, 2026
Price at call$18.79
6-month call Neutral +0.6%
Target by Mar 2027$18.90
Great value below$9.00
Modelv0.6.0
Projection vs Actual
(6M history + forecast)
The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+0.6% to $18.90
Predicted High$20.10at 2 months
Predicted Low$18.45in 2 weeks
Max Drawdown (predicted)-1.8%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Sep 11, 2026 1:00 pm
Neutral
ODD trends range-bound to
$18.90
(+0.6% from $18.79)
by Mar 2027.
ride-then-fade
ThesisFresh Q2 beat and raised guide give ODD near-term momentum despite risk-off regime, but high beta (2.08) and negative quality/value scores drag it back toward DCF fair value ($19) over the medium term with no earnings catalyst in the window.
Invalidated ifBreak below $15.50 on volume or above $23 sustained would falsify the mean-reversion path
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $18.79 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Sep 11, 2026
—
$18.79at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 25, 2026
$15.15–$22.43typical range · internal point $18.45
—
±19.4%
6/10
Risk-off regime pressures high-beta names near term
What actually happened:
closed $18.07
on Sep 24, 2026 = -3.8% vs the call
(predicted -1.8%)
· direction HIT
(called flat, was flat)
· off by 2.0 pp
· accuracy 9/10
· typical range ±19.4%:
inside the band
· S&P +0.6%
over the same window — beat it
1 month
Oct 11, 2026
$13.51–$24.07typical range · internal point $19.20
—
±28.1%
5/10
Sentiment tailwind reasserts as regime stabilizes
2 months
Nov 11, 2026
$20.10
—
+7.0%
5/10
Visionary-founder narrative and raised guide lift shares
3 months
Dec 11, 2026
$19.75
—
+5.1%
4/10
Momentum fades without new catalyst into year-end
4 months
Jan 11, 2027
$19.30
—
+2.7%
4/10
Value gravity pulls toward DCF anchor near $19
5 months
Feb 11, 2027
$18.60
—
-1.0%
4/10
Quality and forensic concerns weigh as narrative cools
6 months
Mar 11, 2027
$18.90
—
+0.6%
3/10
Settles near deterministic baseline awaiting next print
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$19.90
(+5.9%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.